MedTrace Logo

Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450

NCT01091649 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-12-21

No results posted yet for this study

Summary

The objective of this study is to assess the relative bioavailability of two test tablet formulations of ABT-450 as compared to the ABT-450 hard gelatin capsule formulation as a reference.

Conditions

  • Healthy

Interventions

DRUG

ABT-450

Low dose ABT-450 / ritonavir see Arm Description for more information

DRUG

ritonavir

ritonavir see Arm Description for more information

DRUG

ABT-450

High dose ABT-450 / ritonavir See Arm Description for more information

Sponsors & Collaborators

Principal Investigators

  • Adebayo Lawal, M.D. · Abbott

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01091649 on ClinicalTrials.gov